1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc.

ADXS
Ayala Pharmaceuticals, Inc.US flagOther OTC
0.60
USD
- -
- -
25.71MMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
- -
2
4
4
1
- -
+ Sales & Services Revenue
- -
2
4
4
1
- -
- Cost of Revenue
- -
1
4
4
1
- -
+ Cost of Goods & Services
- -
1
4
4
1
- -
Gross Profit
- -
1
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
9
19
30
39
38
36
+ Selling, General & Admin
3
4
7
9
10
12
+ Research & Development
6
14
22
30
28
24
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-9
-18
-30
-39
-38
-36
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
16
+ Interest Expense, Net
- -
- -
- -
- -
- -
16
+ Interest Expense
- -
- -
- -
- -
- -
16
- Interest Income
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
Pretax Income
-9
-17
-30
-39
-37
-52
- Income Tax Expense (Benefit)
- -
- -
- -
1
1
-4
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-9
-18
-30
-40
-38
-48
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-9
-18
-30
-40
-38
-48
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-9
-18
-30
-40
-38
-48
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-9
-18
-30
-40
-38
-48
EBIT
-9
-18
-30
-39
-38
-36
EBITDA
-9
-18
-30
-39
-37
-36
EBITDA Margin (%)
- -
-752.4
-798.14
-1,113.8
-5,396.1
-276,130.77
EBITA
-9
-18
-30
-39
-38
-36
Gross Margin (%)
- -
44.94
- -
- -
13.01
- -
Operating Margin (%)
- -
-758.83
-803.05
-1,118.6
-5,419.51
-278,969.23
Profit Margin (%)
- -
-762.3
-813
-1,148.15
-5,493.21
-369,784.62
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
7
9
10
14
3
6
Basic EPS, GAAP
-1.31
-2.07
-3.06
-2.8
-13.13
-7.99
Basic EPS from Cont Ops
-1.31
-2.07
-3.06
-2.8
-13.13
-7.99
Diluted Weighted Avg Shares
7
9
10
14
3
6
Diluted EPS, GAAP
-1.31
-2.07
-3.06
-2.8
-13.13
-7.99
Diluted EPS from Cont Ops
-1.31
-2.07
-3.06
-2.8
-13.13
-7.99

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
27
18
44
40
3
8
+ Cash, Cash Equivalents & STI
26
17
42
37
2
5
+ Cash & Cash Equivalents
26
17
42
37
2
5
+ ST Investments
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
1
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
1
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
- -
2
3
1
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
2
2
1
5
9
+ Property, Plant & Equip, Net
- -
1
1
1
2
1
+ Property, Plant & Equip
- -
2
2
2
3
1
- Accumulated Depreciation
- -
- -
- -
- -
1
1
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
- -
- -
2
8
+ Total Intangible Assets
- -
- -
- -
- -
- -
8
+ Goodwill
- -
- -
- -
- -
- -
4
+ Other Intangible Assets
- -
- -
- -
- -
- -
4
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
- -
- -
2
- -
Total Assets
27
20
46
41
8
17
+ Payables & Accruals
2
5
6
5
6
12
+ Accounts Payable
1
3
4
3
4
6
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
2
2
2
2
6
+ ST Debt
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
1
1
- -
12
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
1
1
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
12
Total Current Liabilities
3
5
7
6
6
25
+ LT Debt
- -
- -
1
- -
1
8
+ LT Borrowings
- -
- -
- -
- -
- -
8
+ LT Finance Leases
- -
- -
1
- -
1
- -
+ Other LT Liabilities
46
53
- -
- -
1
8
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
46
53
- -
- -
1
8
Total Noncurrent Liabilities
46
54
1
- -
3
16
Total Liabilities
49
59
7
7
9
41
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
2
109
145
148
173
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
2
109
145
148
173
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-23
-41
-71
-111
-149
-197
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-22
-39
38
34
-1
-24
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-22
-39
38
34
-1
-24
Total Liabilities & Equity
27
20
46
41
8
17
Shares Outstanding
12
12
13
14
15
12
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
1
- -
2
- -
Net Debt
-26
-17
-42
-37
-2
3
Net Debt to Equity
119.39
42.97
-109.45
-108.27
219.11
-13.35
Tangible Common Equity Ratio
-80.59
-194.08
83.79
83.05
-14.15
-401.11
Current Ratio
9.68
3.34
6.43
6.14
0.51
0.3
Cash Conversion Cycle
- -
-513.38
-270.6
-325.8
-2,149.51
-139,289.62

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-9
-18
-30
-40
-38
-48
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
1
1
2
3
2
17
+ Stock-Based Compensation
1
1
2
3
2
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
- -
16
+ Chg in Non-Cash Work Cap
2
2
1
-1
1
1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
1
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
- -
-1
-1
2
-1
+ Inc (Dec) in Accts Payable
2
2
2
- -
-1
3
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-6
-15
-28
-38
-35
-29
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-1
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
-1
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
53
33
- -
20
+ Increase in Capital Stock
- -
- -
53
33
1
20
+ Decrease in Capital Stock
- -
- -
- -
- -
-1
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
2
+ Cash from Divestitures
- -
- -
- -
- -
- -
2
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
4
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-2
- -
- -
- -
6
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
6
+ Cash From Debt
- -
- -
- -
- -
- -
6
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
25
7
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
25
7
53
33
- -
26
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
19
-9
26
-5
-35
2
EBITDA
-9
-18
-30
-39
-37
-36
EBITDA Margin (%)
- -
-752.4
-798.14
-1,113.8
-5,396.1
-276,130.77
Free Cash Flow
-7
-16
-28
-38
-35
-29
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
-2
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-16
-28
-38
-35
-23
Free Cash Flow per Basic Share
-0.97
-1.9
-2.8
-2.66
-11.92
-4.9
Price/Free Cash Flow
-253.57
-43.23
-10.01
-4.67
-0.1
-0.14
Cash Flow to Net Income
0.72
0.84
0.91
0.95
0.91
0.61
Capital Expenditures
- -
-1
- -
- -
- -
- -